Talia H Swartz, MD, PhD
- ASSOCIATE DEAN FOR MD/PHD EDUCATION
- ASSOCIATE PROFESSOR | Medicine, Infectious Diseases
- ASSOCIATE PROFESSOR | Medical Education
Specialty:
Infectious DiseaseResearch Topics:
Cellular Immunity, Cytokines, HIV/AIDS, Imaging, Immunology, Infectious Disease, Inflammation, Membrane Proteins/Channels, Membranes, Microbiology, Microglia, Mucosal Immunology, Opioid/Cannabinoid Receptors, T Cells, Translational Research, Transporters, Virulence Genes, Viruses and VirologyTalia Swartz, MD, PhD, is Associate Professor in the Department of Medicine, Division of Infectious Diseases and Medical Education. She is board certified in Internal Medicine and Infectious Disease. Her clinical training is in Infectious Diseases with a specific interest in care for people with HIV and her basic science interest is in the biology that underlies chronic HIV infection and severe COVID-19. Her NIH-funded research laboratory investigates the signaling that mediates inflammatory signaling in response to infection and aims to develop novel treatment paradigms that reduce the morbidity and mortality of HIV-1 disease and COVID-19.
Dr. Swartz is Director of the MD/PhD Program and Senior Associate Dean for MD/PhD Education. She has been deeply committed to supporting the training of physician scientists through recruitment and support of diverse trainees who are navigating dual training in medicine and biomedical science. She is involved in innovative curricular development, outreach, and student support, both at the Icahn School of Medicine at Mount Sinai and through the AAMC GREAT Group MD/PhD Section Communications Committee where she has been developing resources to make physician scientist training available to a more diverse group of future trainees.
Follow on Twitter @taliaswartz
Clinical Focus
- HIV
- HIV and AIDS
Multi-Disciplinary Training Areas
Immunology [IMM], Microbiology [MIC]Education
PhD, Mount Sinai School of Medicine
MD, Mount Sinai School of Medicine
Residency, Internal Medicine, The Mount Sinai Hospital
Fellowship, Infectious Diseases, The Mount Sinai Hospital
-
2021
Junior Faculty Research Award -
2021
Fellow -
2020
Master Educator -
2020
Distinguished Scholar Award -
2019
Excellence in Teaching Award -
2018
Edward J. Ronan Award -
2017
Translational Collaborative Research Development Award -
2016
Junior Faculty Award -
2013
Alpha Omega Alpha Postgraduate Research Award -
2011
Alpha Omega Alpha, Resident/Fellow Member -
2010
House Staff Excellence in Teaching Award
Elucidating the mechanisms of cannabinoids on HIV-1 infection and inflammasome activation
Recent evidence has suggested an important role of the NLRP3 inflammasome as a driver of inflammation. Cannabinoids have been shown to reduce inflammasome activity. What remains unknown is the effect that cannabinoids have on HIV-stimulated NLRP3 inflammasome activity. Our goal is to elucidate the role of cannabinoids in modulating HIV-inflammasome signaling in lymphoid tissue.
Building a diverse and robust physician scientist pipeline
The lack of diversity in gender, race/ethnicity, of the physician scientist pipeline threatens the ability of the biomedical workforce to serve the needs of our patients. There is a critical need for us to expand the diversity of the physician scientist workforce through recruitment, admissions, and retention efforts.
Dissecting the mechanisms of HIV-1 infection and inflammatory signaling in human lymphoid tissue
Purinergic receptors and downstream inflammasome signaling mediators are important contributors to HIV-1 entry and in driving inflammation. Preliminary data indicate that inhibitors of purinergic signaling reduce both HIV-1 infection and inflammatory cytokine signaling. Our goal is to elucidate the role of HIV-1 in mediating inflammatory signaling in lymphoid tissue.
Functional Assessment of anti-Env and inflammatory markers during delayed FTR-mediated virologic control
The goal of this study is to test the role of enhanced antibody responses in the delayed virologic control observed in Fostemsavir treated patients who have multidrug resistant HIV.
Modeling HIV microglia-association infection and inflammation in a chimeric mouse brain
To better understand how HIV affects the brain in the era of combination antiretroviral therapy, and to improve current treatment options, we will study the cell susceptible to HIV infection human microglia, in the mouse brain. This includes novel experimental therapies of antiretrovirals combined with cannabinoid receptor-specific drugs that could lower the extent of inflammation and infection in the brain.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Swartz did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.